32 devices · GMDN 62768
ETS-related gene (ERG) protein in vitro diagnostic (IVD) antibody tests detect the presence of ERG protein in clinical samples, such as tissue biopsies or cytology specimens. These tests are primarily used in pathology to aid in diagnosing prostate cancer and distinguishing it from other benign prostate conditions, helping guide treatment decisions.
These devices are typically regulated as IVDs, with classification and supply depending on the jurisdiction and intended use. They are often supplied as reagents, kits, or ready-to-use solutions for laboratory or point-of-care testing, requiring proper validation and compliance with diagnostic accuracy standards.
This category summary is AI-generated from the GMDN nomenclature and has not been verified by a human reviewer.